Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Puumala Hantavirus Infection in France: Evaluation of Commercial Assays for the Detection of Antibodies Against This Virus and the Use of Urine Samples for the Molecular Detection of This Infection

NCT02455375 is registered in ClinicalTrials.gov with Centre Hospitalier de Charleville-Mézières as lead sponsor.

NCT NCT02455375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02455375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Puumala Hantavirus Infection in France: Evaluation of Commercial Assays for the Detection of Antibodies Against This Virus and the Use of Urine Samples for the Molecular Detection of This Infection
Lead sponsor
Centre Hospitalier de Charleville-Mézières
Phase
Observational
Overall status
Completed
Start date
July 31, 2015
Completion date
November 30, 2021
Enrollment
179 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic fever with renal syndrome, nephropathia epidemica